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Abstract: B a c k g r o u n d / A i m s: Th e aim of the study was to analyze the eff ect of celiac disease (CED) 
on the upper-gut motility and release of enteral hormones (ghrelin and pancreatic peptide (PP)). 
M a t e r i a l s  a n d  m e t h o d s: Th e study included 25 patients diagnosed with CED and 30 healthy 
controls. Gastric myoelectric activities (EGG) in a fasted and fed state were recorded. Th e plasma con-
centrations of ghrelin and PP were determined. 
R e s u l t s: CED patients presented in a fasted state a decreased percentage of normogastria 54.8 ± 24.5 
vs. 86 ± 12.3%, p = 0.02 and slow wave coupling (SWC) 52.7 ± 13.4 vs. 77.4 ± 11.9%; p = 0.00001 with 
increased dominant power (DP) 11.6 ± 1.5 vs. 11.1 ± 1.1. Contrary to the controls, they did not show an 
improvement in the percentage of normogastria, DP and SWC when examined in a fed state (p <0.05). 
Furthermore, CED patients presented with signifi cantly lower fasting plasma concentrations of ghrelin 
156.8 ± 86.7 vs. 260.2 ± 87.6 pg/ml, p = 0.0002 and signifi cantly higher fasting PP levels than did the 
controls 265.2 ± 306.3 vs. 54.1 ± 54.6 pg/ml, p = 0.0005. 
C o n c l u s i o n: CED aff ects gastric myoelectric activity (decreasing normogastria and coupling) and 
causes changes in fasting concentrations of enteral hormones (decrease in ghrelin and an increase in PP). 
Gastric myoelectric response to food is abolished in CED patients, probably due to the neurohormonal 
changes induced by primary infl ammation associated with this disease.
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Introduction 
Celiac disease (CED) is an immune-mediated enteropathy triggered by gluten expo-
sure among susceptible subjects [1–4]. It aff ects approximately 0.3–2.4% of European 
population [1]. Clinical outcome comprises both intestinal and extra-intestinal mani-
festations. Th e most typical, albeit nonspecifi c, symptoms of CED include diarrhea, 
abdominal pain, dyspepsia, fl atulence, malabsorption and weight loss. Extra-intestinal 
manifestations may comprise neurological dysfunction in form of polyneuropathy or 
autonomic impairment [3].
About 30–60% of CED patients present with symptoms that likely correspond 
to gastrointestinal (GI) motility disorders [4]. Alterations of gastrointestinal motility 
observed in patients with CED include impaired esophageal transit, delayed 
orocecal transit time and faster colonic transfer [5, 6]. Th ese abnormalities result 
from malabsorption, autonomic disturbances, enteral hormone derangement and 
interactions thereof [5]. Untreated CED patients were shown to present with a delayed 
gastric emptying, which eventually normalized aft er gluten withdrawal [5, 6]. 
Gastric motility may be examined by means of gastric emptying measurement or 
gastric myoelectric activity recording (electrogastrography, EGG). While the former 
technique can be used solely to determine the postprandial motor status, the latter 
accurately determines gastric motor function in both fed and fasted state [7, 8]. 
Parallel evaluation of gastric emptying and myoelectric activity, with an analysis of 
a relationship between clinical features and characteristics of the recorded gastric 
dysmotility, was a subject of few previous studies in patients with various disorders 
[6, 8–10]. Delayed gastric emptying was shown to be linked to EGG changes, 
namely a lower percentage of normal gastric slow waves and a lower postprandial 
increase in dominant power (DP) of EGG. A canine study demonstrated that 
while each gastric slow wave is accompanied by a contraction, the latter is lost in 
the case of a  dysrhythmia; furthermore, a relative increase in EGG DP was shown 
to be associated with an increase in gastric contractile activity [11]. An increase 
in the percentage of normal slow waves, dominant frequency (DF) and dominant 
power, as well as a  concomitant decrease in the parameters of dysrhythmia, 
are typically observed in healthy subjects as a gastric myoelectric response to 
food [11]. 
Ghrelin and pancreatic polypeptide (PP) among other functions play crucial roles 
in enterohormonal regulation of gastrointestinal motility. Ghrelin is a peptide with 
multiple functions, among others being involved in the control of GI motility, acid 
secretion and regulation of food intake; furthermore, it exerts an anti-infl ammatory 
eff ect in the GI mucosa [12]. Plasma concentration of ghrelin is decreased in the case 
of positive energy balance and increases during starvation [13]. Ghrelin stimulates 
both food intake and GI motility and suppresses insulin secretion. It induces 
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premature phase III contractions and its release is believed to be mediated by the 
vagal stimulation [14]. Several GI disorders were shown to be associated with an 
impaired secretion of ghrelin [12]. Due to the role of ghrelin in the control of food 
intake, any disruptions of this hormone result in an impairment of GI motility and 
gastric acid secretion [12, 15]. However, the available data on plasma concentration of 
ghrelin in CED are inconclusive, probably due to the fact that the latter condition is 
associated with malnutrition and motility disturbances [16–18].
PP is secreted by the Langerhans islets (PP cells) and intestinal cells [19]. 
Postprandial changes in PP concentration correlate with caloric value of a meal. 
Following ingestion of nutrients, circulating PP concentrations increase in a biphasic 
manner, proportionally to caloric load, and remain elevated up to 6 h aft er the meal 
[19]. Physiological eff ects of PP include inhibition of gastric emptying, gallbladder 
motility and pancreatic exocrine secretion [19]. Moreover, an increase in the 
concentration of this enteral hormone was demonstrated to be linked to reduction 
of gastric emptying. To this date, secretion of the gut-brain axis peptide hormones in 
children and adults with CED was examined prior to and during the treatment [20]. 
Chronic infl ammation of the small bowel observed in patients with CED may lead 
to autonomic disturbances and resultant impairment of anti-infl ammatory response 
associated with overactivity of the vagal nerve. 
Impaired motility in CED may be directly linked to changes in ghrelin and PP 
release, their circulating concentrations and/or receptor binding, or occur secondarily 
to infl ammatory damage of neurochemical gastric motility coding. Th e available data 
on gastric motility changes and ghrelin response in CED patients are inconclusive 
and sparse. Presence of gastric pathologies may be refl ected by abnormalities of EGG 
recordings. Th e food-induced changes in gastric myoelectric activity of CED patients 
have not been studied thus far. Furthermore, to the best of our knowledge, none of 
the previous studies analyzed an association between EGG recordings, ghrelin and PP 
concentrations in individuals with CED.
Th erefore, the aims of this study were to examine the changes of gastric myoelectric 
activity and circulating concentrations of ghrelin and PP in patients with CED and 
attempt to answer what is the mechanism of the origin of these disturbances.
Materials and methods
Clinical procedure
Th e study included 55 participants who were divided into the following groups: 
• CED group — 25 symptomatic patients with CED (8 men, 17 women, mean age 
42.4 ± 15.8 years)
• CG — Control group — 30 healthy controls (9 men, 21 women, mean age 
42.1 ± 9.2 years) without a history of GI disorders.
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The presence of CED was confirmed on the basis of serological tests: anti-
endomysial antibodies (EmA) and anti-tissue transglutaminase (tTG) antibodies 
and duodenal histopathology. Detailed characteristics of the study participants are 
presented in Table 1.
Th e exclusion criteria of the study were: GI disorders other than CED, diabetes 
mellitus, obesity (Body Mass Index — BMI ≥30kg/m2), tobacco smoking, alcohol 
abuse, intake of medications with known interference with gastric myoelectric activity 
and autonomic function, history of abdominal surgeries or chronic disorders.
Table 1. Clinical characteristics of the study participants.
Parameters Celiac disease(N = 25)
Control group
(N = 30) p
Age (years) 42.4 ± 15.8 42.1 ± 9.2 NS
Sex (female/male) 17/8 (68%/32%) 21/9 (70%/30%) NS









Anti-tissue transglutaminase antibodies (U/ml) 138.5 ± 80,4 12.4 ± 6.2 —
BMI (kg/m2) 21.7 ± 2.65 23.8 ± 0.6 NS
Albumin (g/dl) 43.6 ± 5.1 58.7 ± 4.2 <0.05
CRP (mg/l) 2.1 ± 0.4 1.2 ± 0.5 NS
Lymphocyte (103/μl) 1742.9 ± 849.5 2032.9 ± 946.2 NS
p < 0.05 — statistically signifi cant; NS non-signifi cant (Student t-test)
All subjects were asked to fast for at least 12 hours prior to the study and to 
refrain from medications with a known eff ect on the autonomic function and GI 
motility during three days preceding the study.
Assessment of gastric myoelectric activity
Electrogastrography (EGG)
30-minute recordings of gastric myoelectric activity (EGG) under basal conditions were 
obtained in both groups aft er an overnight fast and one hour aft er a standard meal 
(Nutridrink, Nutricia, 300  kcal/300 ml). Th e EGG was conducted with a four-channel 
electrogastrography Polygraf NET (Medtronic, USA) as described by Th or et  al. [21].
The following EGG parameters were evaluated: percentage of dysrhythmia 
time (0.5–2 cycles per minute (cpm) — bradygastria; 4–10 cpm — tachygastria), 
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percentage of normogastria (2–4 cpm), dominant frequency (DF), dominant power of 
dominant frequency (DP) and percentage of time with slow-wave coupling between 
2–3 channels (SWC). Period Dominant Frequency (DF) was calculated as an average 
value for the dominant frequencies (highest peak) of FFT (Fast Fourier Transform) 
line. Period Dominant Power (DP) was defi ned as the power or amplitude of the 
DF peak. Changes in the EGG dominant power likely refl ect gastric contractility 
[21, 22]. Gastric myoelectric activity includes slow waves (referred to as electrical 
control activity) and spike potentials associated with electrical response activity [11]. 
Th e frequency of normal gastric slow waves (normogastria) in humans corresponds 
to approximately 3  (2 to 4) cpm and lasts >70% of time. Potential deviations 
from normogastria include gastric dysrhythmias (bradygastria, tachygastria and 
arrhythmia), electro-mechanical uncoupling and abnormal slow wave propagation 
[11, 22].
Biochemical assays
Th e list of analyzed biochemical parameters included serum concentrations of thy-
roid-stimulating hormone (TSH), calcium and albumin, concentration of hemoglob-
in, mean corpuscular volume, erythrocyte and lymphocyte counts, INR (International 
Normalized Ratio) and the level of C-reactive protein (CRP) as a  marker of infl am-
mation. Serum samples were obtained shortly before the EGG recording.
Plasma concentrations of ghrelin and PP were determined at rest in a fasted state. 
Blood samples were stored at ice until centrifuged (3800 g at 8°C for 10 minutes) to 
separate the plasma as soon as possible aft er obtaining. Supernatant was aspirated and 
stored until analysis (6 h to 1 month at –20°C). Plasma concentration of ghrelin was 
determined with Human (Active) Ghrelin ELISA kit (Demeditec Diagnostic GmbH, 
Germany) for automated systems, and concentration of PP with Human Pancreatic 
Polypeptide ELISA kit (EMD Milipore Corporation, USA), both used in line with the 
manufacturers’ instructions. Th e sensitivity of the ghrelin and PP assays was 25 pg/ml 
and 12.3 pg/ml, respectively.
Histopathology
Histopathological specimens were typed according to a 5-step Marsh scale which scores 
the presence of mucosal villous atrophy, crypt hyperplasia and intra epithelial lym-
phocyte eff usion. Type 0 of the scale corresponds to normal mucosa, type I (infi ltrative) 
to increased number (>25) of intraepithelial CD3+ lymphocytes per 100  enterocytes, 
type  II (hyperplastic) to increased crypt hyperplasia with normal villi, types  III A–C 
to CD3+ lymphocyte eff usion, crypt hyperplasia and villous atrophy of various severity 
(from mild to total), and type IV to total villous atrophy and lack of crypt hyperplasia. 
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Types III A–C represent histological changes being typically associated with CED [2, 3]. 
Histopatological examinations were performed in Department of Pathology.
Bioethics
Th e study was conducted in accordance with the Helsinki Declaration and its protocol 
was approved by the Local Bioethics Committee (permission no. KBET/148/B/2012). 
All participants gave their written informed consent to participate in the study.
Statistical analysis
Statistical analysis of the results was conducted with soft ware STATISTICA 10.0 pack-
age license for our University (StatSoft  Inc., Tulsa, OK, USA). Normal distribution 
of each variable was verifi ed with the Shapiro–Wilk test. Student t-test for depend-
ent variables and Wilcoxon singed rank test were used for intragroup comparisons 
of normally and non-normally distributed variables, respectively. Intergroup compari-
sons were conducted with Student t-test for independent variables or Mann-Whitney 
U-test. Direction and power of relationships between pairs of quantitative variables 
were assessed on the basis of Spearman’s coeffi  cients of rank correlation. Th e thresh-
old of statistical signifi cance for all the tests was set at p <0.05.
Results
Biochemical parameters
All participants were euthyroid and presented with normal total blood counts, CRP, 
calcium and albumin levels. Nevertheless, we found a signifi cant intergroup diff erence 
in albumin concentration.
Histopathological fi ndings
CED patients presented with histopathological changes corresponding to type I (in-
fi ltrative) and type III (A–C) characterized by intraepithelial lymphocyte eff usions, 
crypt hyperplasia and villous atrophy (from mild to total).
EGG parameters
Compared to the controls, CED patients presented with a decreased percentage of time 
with normogastria and SWC with increased dominant power (log DP) when examined 
in a fasted state. In turn, the percentages of time with tachygastria, bradygastria and ar-
rhythmia in CED patients were signifi cantly higher than in the controls (Fig. 1, Table 2).
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Fig. 1. Comparison of preprandial EGG parameters in patients with celiac disease and healthy controls. 
SWC — coupling of slow wave, DP — dominant power; * — p = 0.02; ** — p = 0.00001; statistically 
signifi cant intergroup diff erences.
Table 2. EGG parameters determined in a fasted and fed state. 
EGG parameters Celiac disease Control group p
Rest (Fasting state)
DF (cpm/min) 2.5 ± 0.6 3.0 ± 0.6 0.009
DP (log) 11.6 ± 1.5 11.1 ± 1.1 NS
Normogastria (%) 54.8 ± 24.5 86.0 ± 12.3 0.02
Bradygastria(%) 7.9 ± 7.3 2.6 ± 4.3 0.001
Tachygastria(%) 7.9 ± 7.3 2.6 ± 4.3 0.02
Arrhythmic(%) 29.0 ± 15.9 8.5 ± 8.5 0.00001
SWC (%) 52.7 ± 13.4 77.4 ± 11.9 0.00001
Aft er meal (Feeding state)
DF (cpm/min) 2.6 ± 0.7 3.1 ± 0.3 0.002
DP (log) 11.42 ± 1.4 11.49 ± 1.2 NS
Normogastria (%) 54.9 ± 20.4 87.1 ± 9.0 0.00001
Bradygastria (%) 7.4 ± 6.2 2.8 ± 4.1 0.001
Tachygastria (%) 10.1 ± 8.2 4.9 ± 4.5 0.004
Arrhythmic (%) 26.7 ± 16.0 5.2 ± 5.9 0.00001
SWC (%) 59.1 ± 14.5 82.7 ± 10.8 0.00001
DF — dominant frequency; DP — dominant power of dominant frequency; SWC — percentage of slow-wave cou-
pling between 2–3 channels; NS — non-signifi cant.
64 Magdalena Przybylska-Feluś, Agata Furgała, et al.
When examined in a fed state, CED patients did not show an improvement in the 
percentage of time with normogastria, log DP, dominant frequency and slow wave 
coupling. In contrast, a signifi cant increase in log DP, DF, SWC and percentage of 
time with normogastria was observed in the controls when compared to the respective 
parameters determined in a fasted state (p <0.05) (Fig. 2, Table 2). However, the 
disturbances of slow wave frequency did not improve aft er a standard meal.
Fig. 2. Comparison of postprandial EGG parameters in patients with celiac disease and healthy controls. 
SWC — coupling of slow wave, DP — dominant power; ** — p = 0.00001 — statistically signifi cant 
intergroup diff erence. 
Enterohormone levels
While fasting plasma concentration of ghrelin was signifi cantly lower in CED patients 
than in the controls (156.8 ± 86.7 pg/ml vs. 260,2 ± 87.6 pg/ml, p = 0.0002), their 
fasting plasma level of PP turned out to be signifi cantly higher (265.2 ± 306.3   pg/ml 
vs. 54.1 ± 54.6 pg/ml, p = 0.0005) (Fig. 3).
Correlations
An analysis of associations between fasting plasma concentrations of enterohor-
mones and EGG parameters of CED patients showed a signifi cant positive correla-
tion between the level of ghrelin and percentage of time with preprandial bradygastria 
 Ghrelin, PP and EGG in celiac disease 65
(r  =  0.42, p = 0.049), as well as an inverse correlation between the ghrelin concen-
tration and preprandial DP (r = –0.54, p = 0.049). In turn, fasting plasma level of 
PP was shown to correlate positively with the percentage of time with postprandial 
tachy gastria (r  =  0.42, p = 0.049). Furthermore, duration of the disease was demon-
strated to correlate positively with both percentage of time with postprandial tach-
ygastria and postprandial DP (r = 0.52, p = 0.01; r = 0.62, p = 0.03) (Table 3). No 
 signifi cant correlations were found between the levels of infl ammatory markers, fast-
ing ghrelin and PP plasma concentrations and EGG parameters.
Table 3. Correlations between the EGG parameters, serum enterohormonal levels and duration of celiac 
disease.
Parameters R P
Ghrelin & preprandial DP –0.54 0.049
Ghrelin & preprandial % bradygastria  0.42 0.049
Pancreatic polypeptide & % postprandial tachygastria  0.42 0.049
Postprandial DP & duration of celiac disease  0.62 0.03
Postprandial tachygastria & duration of celiac disease  0.52 0.01
DP — dominant power of dominant frequency.
Fig. 3. Comparison of fasting plasma concentrations of ghrelin and PP in patients with celiac disease and 
healthy controls. * — p = 0.0002, ** — p = 0.0005 — statistically signifi cant intergroup diff erences.
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Discussion
To the best of our knowledge, this was the fi rst study to analyze a relationship be-
tween the EGG parameters and plasma levels of GI peptides, ghrelin and PP, in pa-
tients with CED. Th e results of this analysis suggest that individuals suff ering from 
this condition present with an autonomic nervous system imbalance.
Several previous studies documented a relationship between EGG parameters 
and gastric emptying [9, 10]. Delayed gastric emptying was linked to changes in 
EGG, namely to a decrease in the percentage of normal gastric slow waves and 
lower postprandial increase in DP. We observed an impairment of EGG parameters 
in CED patients. A decrease in the percentage of time with normogastria and SWC, 
with a concomitant increase in log DP, were documented on fasting EGG recordings. 
Moreover, CED patients did not show an increase in the EGG parameters when re-
examined aft er a standard meal. Th e abovementioned EGG changes turned out to be 
associated with a lower fasting plasma concentration of ghrelin. Previous animal and 
human studies showed that ghrelin enhances gastric motility and gastric emptying, 
and a decrease in the concentration of this hormone may result in a delayed gastric 
emptying [15, 20]. Our observation on the preprandial decrease in the percentage 
of time with normogastria is consistent with the data published by Chen et  al., 
who examined patients with gastroparesis, as well as with the results reported by 
Kamiya et al., who studied the group of individuals with dyspepsia and non-erosive 
gastroesophageal disease (NERD) [10, 23]. Since Chen et al. documented a decrease 
in the percentage of time with normogastria and abnormal postprandial DP, it is 
likely that also our patients presented with a delayed gastric emptying. Similarly, the 
lack of increase in power ratio observed by these authors likely corresponded to low 
antral motility and resultant delayed gastric emptying, which also may be extrapolated 
to our CED group. Furthermore, a positive correlation between a 3-cpm amplitude 
observed on EGG and plasma PP immunoreactivity level was previously reported by 
Kaneko et al., pointing to an increase in vagal activity [24]. Th e above mentioned data 
are consistent with the results of present study, namely with the fact that our CED 
patients presented with higher DP than the controls, but showed less pronounced 
increase in this parameter aft er feeding. However, a decrease in DP was previously 
reported by Kamiya et al. in patients with NERD and by Cucciara et al. in children 
with acute symptoms of gastroesophageal refl ux disease (GERD) [9, 23]. Th ese data 
support our primary hypothesis that an infl ammatory damage to the enteric nervous 
system (ENS) is a common consequence of a GI infl ammation. Chronic infl ammation 
may also result in secondary neuroproliferation in the duodenal mucosa as 
previously shown by Leonard et al. [25]. We suggest that these microscopic changes 
may interfere with normal neuronal function, but this concept needs to be verifi ed 
empirically.
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The role of sympathetic activation in modulation of gastric slow waves and 
pathogenesis of CED symptoms have not been established thus far. Dysautonomia 
may also occur concomitantly to other conditions, such as diabetes mellitus, functional 
disorders of the GI tract and sclerodermia. According to McNeamey et al., the dysmotility 
observed in the course of these disorders may result from a primary neuropathic process 
leading to ENS damage [26]. These authors observed both sympathetic activation 
and slow wave activity, but did not explain if the abnormalities of the latter occurred 
secondarily to the autonomic impairment [26]. Our fi ndings are consistent with these 
data supporting the hypothesis that primary inflammatory damage to the enteric 
innervation may result in a subsequent decrease in the release of ghrelin [27].
Contrary to our fi ndings, Capristo et al. and Peracchi et al. observed an increase in 
the ghrelin levels of untreated CED patients [15, 18], with subsequent normalization 
of this parameter aft er switching to a gluten-free diet. Moreover, they demonstrated 
a correlation between the level of ghrelin and severity of infl ammation [17]. Th is 
fi nding was further supported by Cheung et al. and Tack et al. [12, 15]. Th e decrease 
in the concentration of ghrelin observed in our CED patients might be associated 
with the presence of gastric infl ammatory lesions. Zwolinska-Wcislo et al. showed 
that individuals with concomitant CED and lymphocytic gastritis may present with 
severe dyspeptic symptoms [28]. Th erefore, an injury to gastric mucosa may constitute 
a potential underlying mechanism of inhibited ghrelin release.
Our results are partially consistent with the data published by Capristo et al. 
Although these authors did not fi nd a signifi cant diff erence in the concentrations 
of ghrelin of untreated CED patients and healthy controls, they explained this 
phenomenon as a potential consequence of the disease duration, patient sex and age 
[18]. Similar to our study, Cummings et al. observed a decrease in the ghrelin level of 
CED patients and interpreted this fi nding as an eff ect of autoimmune gastrointestinal 
disease [29]. Th e preprandial decrease in the concentration of ghrelin in our CED 
patients may explain the abnormalities documented on their EGG recordings, being 
a likely cause for the delayed gastric emptying. Th e inverse correlation between fasting 
level of ghrelin and preprandial tachygastria observed in our patients suggests that 
a decrease in the concentration of this peptide may be a consequence of slow gastric 
emptying and resultant gastric stasis. Th is in turn leads to a prolonged food retention 
in the stomach [12]. Th e delayed gastric emptying with prolonged food retention in 
the stomach is known to be associated with the occurrence of dyspeptic symptoms, 
such as early satiety, nausea and vomiting [12].
CED may cause disturbances in autonomic system activity (ANS). In line with 
the modes of autonomic control by Berntson [30], we observed a simultaneous 
coupled non reciprocal co-activation of both the ANS arms. Gastric dysmotility, likely 
resulting from an autonomic dysfunction, was previously reported by other authors 
[24, 31]. Due to induced autonomic dysfunction with co-activation of both arms of 
68 Magdalena Przybylska-Feluś, Agata Furgała, et al.
the autonomic nervous system, our CED patients showed diminished response to 
parasympathetic stimulation (as confi rmed by the preprandial increase in DP and 
elevated fasting plasma concentration of PP). We previously showed that CED patients 
frequently present with dysautonomia in form of the sympathetic overdrive [32]. Also 
other authors consistently reported sympathetic activation in CED patients [24]. 
Huda at al. showed that ghrelin inhibits activity of the sympathetic nervous system 
(SNS) in healthy controls, but exerts only a moderate eff ect on their parasympathetic 
nervous system (PNS) [33]. In the abovementioned study, vagotomized subjects 
did not respond to ghrelin, which suggests that vagus nerve plays an important 
role in transmitting the eff ects of peripheral ghrelin to the SNS. Low concentration 
of ghrelin and concomitant increase in the sympathetic drive point to likely lack of 
reciprocal SNS inhibition in our patients. Also PNS was postulated to be involved in 
the induction of ghrelin secretion [34]. While an increase in the circulating ghrelin 
level in humans was shown to be simulated by cholinergic agonists, cholinergic 
antagonists were demonstrated to cause a decrease in this parameter. Vagus nerve is 
known to play an important role in signaling between peripheral ghrelin and central 
appetite centers. Th is points to potential involvement of various pathophysiological 
mechanisms, such as intestinal infl ammation and visceral sensitization in food intake 
control. Our results may have some implications for symptomatic treatment of CED, 
as modulation of the sympathetic tone may result in changes in gastric motility.
Th e eff ects of ghrelin on the activity of SNS and PNS in humans have not been 
studied in detail to this date. Central nervous system (CNS) communicates directly 
with the intestine via the brain-gut axis. CNS recognizes GI infl ammation present 
in CED patients as an activation of vagal aff erent signaling. Infl ammatory signals 
generated within the bowel may signifi cantly alter peripheral neuronal signaling, 
which results in both peripheral and central sensitization, a phenomenon that is 
refl ected by an enhanced aff erent neuronal activation [35, 36]. As shown recently, 
the brain not only “detects” peripheral infl ammation via the aff erent vagal fi bers, but 
also attenuates the innate immune activation due to an integrated neural response 
involving massive activation of the vagal eff erent fi bers. Th is eff erent arm of the 
infl ammatory refl ex is referred to as the “cholinergic anti-infl ammatory pathway”. 
Infl ammatory refl ex constitutes a crucial homeostatic system. A number of previous 
studies showed that the release of PP from the pancreas is under vagal control 
and therefore may be used as a marker of the vagal eff erent activity [37]. As direct 
measurement of the vagal eff erent activity is not possible due to rapid degradation of 
acetylcholine, we used the PP response as an indicator of visceral vagal activity. Such 
experimental approach may provide an insight into the physiological conditions under 
which vagal eff erent fi bers can be evaluated. Th is hypothesis seems to be strongly 
supported by clinical data as signifi cantly elevated fasting plasma concentrations of PP 
were previously demonstrated in both patients with ulcerative colitis and individuals 
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with Crohn’s disease [38, 39]. Th is suggests that infl ammatory bowel disease is likely 
associated with a shift  in the autonomic balance towards a relative parasympathetic 
predominance, even in the case of remission.
Although Papastamataki and Linnestad observed a diff erent secretion pattern of the 
gut-brain axis hormones in children with CED, the PP levels of their patients did not diff er 
signifi cantly from those in adults [20, 40]. In contrast to these authors, we found elevated 
levels of PP in our adult CED patients. Th is discrepancy may be attributed to presence 
of diff erent stages of ANS impairment and/or to diff erences in the immune response of 
children and adults refl ecting a well-known phenomenon of greater ENS neuroplasticity 
in young persons. As mentioned above, in our previous study we demonstrated 
sympathetic overdrive in the same group of CED patients [32]. It should be remembered, 
however, that patients are not homogeneous in terms of their aff ective states, stress 
levels and coping strategies, and all these factors may infl uence their autonomic balance. 
Furthermore, an increase in vagal eff erent activity and/or altered receptor activity may 
change the sensitivity to acetylcholine as a compensatory mechanism.
As an orexogenic hormone, ghrelin is mainly released in the empty stomach. In 
some cases, however, gastric distention developed secondarily to impaired motility of 
the stomach may inhibit the ghrelin release. Moreover, also sympathetic suppression 
observed in CED patients may impair both ghrelin and PP release.
According to Baatar et al., the expression of endogenous ghrelin may play 
a homeostatic role in the immunological reactions involved in CED pathogenesis [35]. 
Probably, ghrelin controls T-cell activity, thus exerting an anti-infl ammatory eff ect, and 
suppresses tumor necrosis factor alpha (TNF alpha) secretion [35, 36]. In our opinion, 
lower level of ghrelin may be refl ected by persistent infl ammatory eff usions around the 
ENS neurons which in turn may lead to either visceral hyperactivity or ANS impairment. 
This hypothesis needs to be verified empirically, and thus an in-depth research is 
required on this specifi c aspect of intestinal immune response [35]. In conclusion, 
the autonomic dysfunction observed in CED patients may affect their GI motility 
with resultant impairment of enterohormonal secretion. Aside from well-established 
role of ANS in the control of GI motility, also eff erent vagal nerve stimulation was 
hypothesized to regulate immune response directly and rapidly. Activation of eff erent 
vagal fi bers results in the release of acetylcholine, which not only inhibits the synthesis 
of pro-infl ammatory cytokines but also causes changes in ghrelin and PP release.
Conclusions
Both our fi ndings and the results of previous studies suggest that CED causes distur-
bances in gastric myoelectric activity and fasting enterohormonal levels as a conse-
quence of infl ammatory damage to the ENS. Th e diminished responsiveness to sym-
pathetic and parasympathetic stimulation points to likely co-activation of both ANS 
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arms as a common pathophysiological mechanism leading to gastric dysmotility in 
CED patients. Th e decrease in plasma concentration of ghrelin and the increase in 
plasma level of PP may lead to delayed gastric emptying in CED patients. Th e altered 
gastric motility may be in turn refl ected by presence of dyspeptic symptoms.
Th e some part of manuscript’s content has been presented before as 
conferences presentation on two Congresses
Title of presentation: “Diminished the upper-gut motility and enterohormons level 
in the celiac disease patients” on XVI Congress of Polish Gastroenterology Society 
25–27.09.2014 in Wrocław, Poland and on 22nd United European Gastroenterology 
UEG Week 18–22.10.2014 Wien, Austria.
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